Results from a report released today in a leading medical journal indicate that low dose daily aspirin reduces the risk of metastasis of several cancers. According to articles in The Lancet, the protective effect occurs within 3-5 years of beginning aspirin use.
Read more about the study in a post from our Cancer Frontline blog.
Raymond DuBois, M.D., Ph.D, MD Anderson's provost and executive vice president and a professor...
Read stories from survivors and caregivers, and get MD Anderson experts’ insights on cancer treatment, research breakthroughs, healthy living and more.